Perioperative Cancer Cell Dissemination and Systemic Immune Suppression in Resectable Ductal Pancreatic Adenocarcinoma

NCT00495924 · clinicaltrials.gov ↗

COMPLETED

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Pancreatic Neoplasms
Adenocarcinoma
Neoplasm Circulating Cells
Tumor Markers, Biological
Monitoring, Immunologic

Interventions

PROCEDURE: Pancreatic resection (PD)

Sponsor

KU Leuven

Collaborators

[object Object]
[object Object]